Click here to watch our Free Stem Cell Count Instructional Video.
In Arena International's Clinical Trial Supply 2020 Virtual Experience online conference, Asymmetrex Director James Sherley discussed unique challenges in the supply chain of therapies for stem cell transplantation medicine, gene therapy, and gene-editing therapy that can be readily addressed by greater use of tissue stem cell counting technologies like those developed by Asymmetrex. In particular, Sherley stressed that certification of the stability of the therapeutic doses of natural and gene-engineered tissue stem cells is essential for elevating the supply of stem-gene clinical trials to greater quality and reliability.
Watch the presentation here.
The long-standing challenge of counting tissue stem cells specifically and accurately is met by Asymmetrex’s Kinetic Stem Cell Counting technology. In March 2020, Asymmetrex Director James Sherley presented the latest advance in the technology at the Perinatal Stem Cell Society’s Annual Congress in Salt Lake City, Utah.
In this video of his presentation, he describes both the theory and the practice of counting perinatal and postnatal tissue stem cells.
Director James Sherley M.D., Ph.D. visits COAACH at North Carolina A&T State University to talk with future biotech entrepreneurs about the principles of biotechnology commercialization illustrated with the origin story of Asymmetrex.
Listen to the talk here.
At the World Drug Safety Congress 2019 (April 16-17), Asymmetrex introduced its AlphaSTEM Test™ to the international pharmaceutical community. By early detection of drug candidates that are stem cell-toxic, Asymmetrex can eliminate drugs that will fail late after great cost because they induce chronic organ failure. By assaying for toxic effects on organ and tissue stem cells specifically, very bad drugs can be identified sooner, without injuring patients, and at greatly reduced development cost. Spend 2 minutes learning more about the technology that Asymmetrex is introducing.
Dr. James L. Sherley speaks at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, Utah, on February 28-March 1, 2019. His talk was about the continued development of a first technology for specific and accurate counting of perinatal and postnatal tissue stem cells. Watch the video here to learn more.
Watch and listen to Director Sherley present at the Cell & Gene Exchange in Washington, DC on May 23, 2017. In this video, you will learn more about the need for stem cell counting and how Asymmetrex’s technologies provide a solution for this overwhelming need and more.
In December 2017, Asymmetrex Director James Sherley presented his new biological concept, “Stem Cell Memory” in the Biomedical & Life Sciences Collection of Henry Stewart Talks. Here is a link to the “Stem Cell Memory” video presentation.
Watch Asymmetrex founder Dr. James Sherley, M.D., Ph.D., speak at the 5th World Congress on Cell and Stem Cell Research in Chicago on March 23, 2015 (click either video to starting watching).
In the first video, Director Sherley discusses, “adult stem cell limitations in current regenerative medicine clinical trials.”
In the second video, Director Sherley talks about “the importance of Asymmetrex’s stem cell technology principle – asymmetric self-renewal – in stem cell medical engineering.”